Lilly's next-gen Triple G (GLP-1/GIP/glucagon) agonist (Phase 1b, Phase 2): started recruiting for a Phase 3 trial this year approvals are expected by 2026
Toss chickpeas into salads, whip up some hummus, or add lentils to soups
For some, the anxiety around self-injection is a significant barrier to starting or continuing treatment
35 Without this stimulus, especially during a calorie deficit potentially exacerbated by GLP-1 effects, the body may be less efficient at utilizing dietary protein for muscle maintenance, leading to greater lean mass loss
Tirzepatide can help clarify which path makes the most sense for your goals
Definition and Overview GLP-1 agonists are synthetic compounds designed to activate the GLP-1 receptors in the body, mimicking the actions of the endogenous GLP-1 hormone